$4.56
0.122.70%
At Close: -
$4.46
-0.1-2.19%
After Hours: Aug 23, 8:48 AM EDT
15 minutes delayed
Comments
Loading...
Eagle Pharmaceuticals (NASDAQ:EGRX) Stock, Earnings Estimates, EPS, And Revenue
Eagle Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 8
EPS
–
Quarterly Revenue
–
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$257.6M
Analyze the earnings history of Eagle Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Eagle Pharmaceuticals (EGRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2023 | 2023-08-08 | $1.18 | $1.05 | 12.4 % |
| Mar 2023 | 2023-05-09 | $1.26 | $1.05 | 20.0 % |
| Dec 2022 | 2023-03-13 | $1.10 | $0.83 | 32.5 % |
| Sep 2022 | 2022-11-07 | $1.12 | $0.91 | 23.1 % |
Eagle Pharmaceuticals (EGRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2023 | 2023-08-08 | $64.65M | $59.35M | 8.92 % |
| Mar 2023 | 2023-05-09 | $66.31M | $63.29M | 4.76 % |
| Dec 2022 | 2023-03-13 | $60.70M | $64.26M | -5.54 % |
| Sep 2022 | 2022-11-07 | $65.90M | $62.08M | 6.15 % |
FAQ
When is Eagle Pharmaceuticals (NASDAQ:EGRX) reporting earnings?
Eagle Pharmaceuticals (EGRX) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on November 8, 2023 for Q3.
What were the latest earnings per share (EPS) for Eagle Pharmaceuticals (NASDAQ:EGRX)?
The Actual EPS was $0.00, which missed the estimate of $1.07.
What were Eagle Pharmaceuticals’s (NASDAQ:EGRX) revenues?
The Actual Revenue was $0K, which missed the estimate of $64.5M.
Browse earnings estimates, EPS, and revenue on all stocks.